author_facet Oppermann, Sina
Ylanko, Jarkko
Shi, Yonghong
Hariharan, Santosh
Oakes, Christopher C.
Brauer, Patrick M.
Zúñiga-Pflücker, Juan C.
Leber, Brian
Spaner, David E.
Andrews, David W.
Oppermann, Sina
Ylanko, Jarkko
Shi, Yonghong
Hariharan, Santosh
Oakes, Christopher C.
Brauer, Patrick M.
Zúñiga-Pflücker, Juan C.
Leber, Brian
Spaner, David E.
Andrews, David W.
author Oppermann, Sina
Ylanko, Jarkko
Shi, Yonghong
Hariharan, Santosh
Oakes, Christopher C.
Brauer, Patrick M.
Zúñiga-Pflücker, Juan C.
Leber, Brian
Spaner, David E.
Andrews, David W.
spellingShingle Oppermann, Sina
Ylanko, Jarkko
Shi, Yonghong
Hariharan, Santosh
Oakes, Christopher C.
Brauer, Patrick M.
Zúñiga-Pflücker, Juan C.
Leber, Brian
Spaner, David E.
Andrews, David W.
Blood
High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells
Cell Biology
Hematology
Immunology
Biochemistry
author_sort oppermann, sina
spelling Oppermann, Sina Ylanko, Jarkko Shi, Yonghong Hariharan, Santosh Oakes, Christopher C. Brauer, Patrick M. Zúñiga-Pflücker, Juan C. Leber, Brian Spaner, David E. Andrews, David W. 0006-4971 1528-0020 American Society of Hematology Cell Biology Hematology Immunology Biochemistry http://dx.doi.org/10.1182/blood-2015-12-687814 <jats:title>Key Points</jats:title> <jats:p>Patient-specific pathways of resistance to venetoclax can be identified by high-content screening of clinical samples with a KI library. Sunitinib may overcome resistance to venetoclax for many patients by downregulating the expression of Bcl-xl, Mcl-1, and A1 in CLL cells.</jats:p> High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells Blood
doi_str_mv 10.1182/blood-2015-12-687814
facet_avail Online
Free
finc_class_facet Biologie
Medizin
Chemie und Pharmazie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDE1LTEyLTY4NzgxNA
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDE1LTEyLTY4NzgxNA
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
imprint American Society of Hematology, 2016
imprint_str_mv American Society of Hematology, 2016
issn 0006-4971
1528-0020
issn_str_mv 0006-4971
1528-0020
language English
mega_collection American Society of Hematology (CrossRef)
match_str oppermann2016highcontentscreeningidentifieskinaseinhibitorsthatovercomevenetoclaxresistanceinactivatedcllcells
publishDateSort 2016
publisher American Society of Hematology
recordtype ai
record_format ai
series Blood
source_id 49
title High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells
title_unstemmed High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells
title_full High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells
title_fullStr High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells
title_full_unstemmed High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells
title_short High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells
title_sort high-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated cll cells
topic Cell Biology
Hematology
Immunology
Biochemistry
url http://dx.doi.org/10.1182/blood-2015-12-687814
publishDate 2016
physical 934-947
description <jats:title>Key Points</jats:title> <jats:p>Patient-specific pathways of resistance to venetoclax can be identified by high-content screening of clinical samples with a KI library. Sunitinib may overcome resistance to venetoclax for many patients by downregulating the expression of Bcl-xl, Mcl-1, and A1 in CLL cells.</jats:p>
container_issue 7
container_start_page 934
container_title Blood
container_volume 128
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792348009674047490
geogr_code not assigned
last_indexed 2024-03-01T18:04:22.473Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=High-content+screening+identifies+kinase+inhibitors+that+overcome+venetoclax+resistance+in+activated+CLL+cells&rft.date=2016-08-18&genre=article&issn=1528-0020&volume=128&issue=7&spage=934&epage=947&pages=934-947&jtitle=Blood&atitle=High-content+screening+identifies+kinase+inhibitors+that+overcome+venetoclax+resistance+in+activated+CLL+cells&aulast=Andrews&aufirst=David+W.&rft_id=info%3Adoi%2F10.1182%2Fblood-2015-12-687814&rft.language%5B0%5D=eng
SOLR
_version_ 1792348009674047490
author Oppermann, Sina, Ylanko, Jarkko, Shi, Yonghong, Hariharan, Santosh, Oakes, Christopher C., Brauer, Patrick M., Zúñiga-Pflücker, Juan C., Leber, Brian, Spaner, David E., Andrews, David W.
author_facet Oppermann, Sina, Ylanko, Jarkko, Shi, Yonghong, Hariharan, Santosh, Oakes, Christopher C., Brauer, Patrick M., Zúñiga-Pflücker, Juan C., Leber, Brian, Spaner, David E., Andrews, David W., Oppermann, Sina, Ylanko, Jarkko, Shi, Yonghong, Hariharan, Santosh, Oakes, Christopher C., Brauer, Patrick M., Zúñiga-Pflücker, Juan C., Leber, Brian, Spaner, David E., Andrews, David W.
author_sort oppermann, sina
container_issue 7
container_start_page 934
container_title Blood
container_volume 128
description <jats:title>Key Points</jats:title> <jats:p>Patient-specific pathways of resistance to venetoclax can be identified by high-content screening of clinical samples with a KI library. Sunitinib may overcome resistance to venetoclax for many patients by downregulating the expression of Bcl-xl, Mcl-1, and A1 in CLL cells.</jats:p>
doi_str_mv 10.1182/blood-2015-12-687814
facet_avail Online, Free
finc_class_facet Biologie, Medizin, Chemie und Pharmazie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDE1LTEyLTY4NzgxNA
imprint American Society of Hematology, 2016
imprint_str_mv American Society of Hematology, 2016
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161
issn 0006-4971, 1528-0020
issn_str_mv 0006-4971, 1528-0020
language English
last_indexed 2024-03-01T18:04:22.473Z
match_str oppermann2016highcontentscreeningidentifieskinaseinhibitorsthatovercomevenetoclaxresistanceinactivatedcllcells
mega_collection American Society of Hematology (CrossRef)
physical 934-947
publishDate 2016
publishDateSort 2016
publisher American Society of Hematology
record_format ai
recordtype ai
series Blood
source_id 49
spelling Oppermann, Sina Ylanko, Jarkko Shi, Yonghong Hariharan, Santosh Oakes, Christopher C. Brauer, Patrick M. Zúñiga-Pflücker, Juan C. Leber, Brian Spaner, David E. Andrews, David W. 0006-4971 1528-0020 American Society of Hematology Cell Biology Hematology Immunology Biochemistry http://dx.doi.org/10.1182/blood-2015-12-687814 <jats:title>Key Points</jats:title> <jats:p>Patient-specific pathways of resistance to venetoclax can be identified by high-content screening of clinical samples with a KI library. Sunitinib may overcome resistance to venetoclax for many patients by downregulating the expression of Bcl-xl, Mcl-1, and A1 in CLL cells.</jats:p> High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells Blood
spellingShingle Oppermann, Sina, Ylanko, Jarkko, Shi, Yonghong, Hariharan, Santosh, Oakes, Christopher C., Brauer, Patrick M., Zúñiga-Pflücker, Juan C., Leber, Brian, Spaner, David E., Andrews, David W., Blood, High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells, Cell Biology, Hematology, Immunology, Biochemistry
title High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells
title_full High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells
title_fullStr High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells
title_full_unstemmed High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells
title_short High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells
title_sort high-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated cll cells
title_unstemmed High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells
topic Cell Biology, Hematology, Immunology, Biochemistry
url http://dx.doi.org/10.1182/blood-2015-12-687814